Hepatitis B and Hepatitis C virus infections in stem cell transplantation

Leukemia and Lymphoma

Volumn 35, Issue 3-4, 1999, Pages 255-260

  Locasciulli, Anna ^a   Alberti, Alfredo ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

HBV; HCV; Hepatitis B and C; SCT; Stem cell transplantation

Indexed keywords

HEPATITIS B; HEPATITIS C; HUMAN; LIVER DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION;

EID: 0032708209     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145728     Document Type: Review

References (30)

1. Scaglioni PP, Melegari M, Wands JR. Recent advances in the molecular biology of hepatitis B virus. In Viral hepatitis, edit. BAILLIERE's Clinical Gastroenterology: 207-225, 1996.
2. Chisari FU, Filippi P, Buras J et al. Structural and pathological effects of synthesis of HBV large envelope polypeptides in transgenic mice. PNAS USA 84: 6909-13, 1987.
3. Gilles PN, Guenette DL, Ulevitch RJ. HBsAg retention sensitises the hepatocyte to injury by physiological concentrations of IFN. JAMA/Hepatology 16: 655-63, 1992.
4. Locasciulli A, Bacigalupo A, VanLint MT,et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 6: 25-29, 1990.
5. Reed E., Myerson D, Corey L. Meyers JD. Allogeneic Marrow Transplantation in patients positive for Hepatitis B Surface Antigen. Blood 77: 195-200, 1991.
6. Locasciulli A, Alberti A, de Bock R, et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group-Infectious Diseases Working Party. Bone Marrow Transplant 14: 833-837, 1994.
7. Chen P, Liu J, Fan FS, et al. Liver disease after bone marrow transplantation-The Taiwan experience. Transplantation 59: 1139-1143, 1995.
8. Lau GKK, Liang R, Chiu EKW, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 19: 795-799, 1997.
9. Locasciulli A, Testa M, Bonizzoni E, Ljungman P, Alberti A. The role of hepatitis C and hepatitis B virus infections as risk factors for severe liver complications following allogeneic bone marrow transplantation (BMT): a prospective study of the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group (1D-WP,EBMT). Hepatology 26: 260A (abstr.), 1997.
10. Pariente EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 33: 1185-91, 1988.
11. Chen PM, Fan S, Hsieh RK, et al. Liver disease in patients with liver dysfunction prior to bone marrow transplantation. Bone Marrow Transplant 9: 415-9, 1992.
12. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T-cell depleted allogeneic bone marrow transplantation. Hepatology 18: 246-52, 1993.
13. McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 121: 274-5, 1994.
14. Brugger SA, Oesterreicher C, Hofmann H, Kalhs P, Greinix HT, Muller C. Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunized donor. Lancet 349: 996-7, 1997.
15. Locasciulli A, Testa M, Valsecchi MG, et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 90: 3799-3805, 1997.
16. Locasciulli A, Bacigalupo A, VanLint MT, et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 52: 315-8, 1991.
17. Shuhart MC, Myerson D, Childs BH, et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 84: 3229-35, 1994.
18. Locasciulli A, Nava S, Sparano P, Testa M. Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 21, suppl 2: S 75-7, 1998.
19. Frickhofen N, Wiesneth M, Fukawa H, et al. Hepatitis C virus infection is a risk factor for liver failure from venoocclusive disease after bone marrow transplantation. Blood 83: 1998-2004, 1994.
20. Strasser SI, Spurgeon CL, Kim S, et al. Hepatitis C virus infection and bone marrow transplantation: a prospective study with 10 year follow-up. Hepatology. 1998 (abstr.) in press.
21. Ljungman P, Hagglund H, Lonnqvist B, Sonnerborg A, Ringden O. Hepatitis C virus as a risk factor for the development of veno-occlusive disease(letter). Blood 84: 1349, 1994.
22. Norol F, Roche B, Saint-Marc Girardin MF, et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 57: 393, 1994.
23. Locasciulli A, Bacigalupo A, VanLint MT, et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 16: 407-11, 1995.
24. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Whithdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 8: 417-20, 1991.
25. Kanamori H, Fukawa H, Maruta A, et al. case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 303: 109-11, 1992.
26. Locasciulli A, Alberti A, Bandini G, et al. Allogeneic bone marrow transplantation from HBsAg positive donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 86: 3236-40, 1995.
27. Martin BA, Rowe JM, Kouides PA, DiPersio JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 15: 145-8, 1995.
28. HBeAg-negative in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD. Bone Marrow Transplant 22: 919-21, 1998.
29. Ljungman P, Johansson N, Galumann H, et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 86: 1614-9, 1995.
30. Strasser SI, Spurgeon CL, Sullivan KM, McDonald GB. Cirrhosis in long-term survivors of marrow transplantation: prevalence and risk factors. Gastroenterology 112: A1391, 1997 (abstr.)